The American Journal of Managed Care13h
Semaglutide Demonstrates Enhanced Walking Capacity in ACC.25 STRIDE Data
STRIDE investigator Marc Bonaca, MD, MPH, University of Colorado School of Medicine, highlights how the data could provide insight into peripheral artery disease and type 2 diabetes treatment options.
Peripheral artery disease often underdiagnosed and undertreated, research finds
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...
Medscape15h
Semaglutide Shows Major Benefits in Peripheral Arterial Disease: STRIDE
The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...
Novo says Ozempic succeeded in late-stage trial for peripheral artery disease
Novo Nordisk (NVO) says its obesity drug Ozempic improved walking distance for diabetes patients with peripheral artery ...
Endocrinology Advisor3d
AHA Scientific Statement: Sex-Based Differences in Peripheral Vascular Disease
A scientific statement regarding sex differences in patients with peripheral vascular disease has been published by the AHA.
ABC Columbia3d
MIDLANDS CARES: Peripheral Arterial Disease
COLUMBIA SC (WOLO) – We all understand the importance of the heart, but there are some other afflictions related to the ...
Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...